<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-3466</journal-id>
<journal-title><![CDATA[Revista Cubana de Salud Pública]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Salud Pública]]></abbrev-journal-title>
<issn>0864-3466</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-34662018000200398</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La política nacional de medicamentos en el contexto de América Latina]]></article-title>
<article-title xml:lang="en"><![CDATA[The National Drugs Policy in the context of Latin America]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jimenez Herrera]]></surname>
<given-names><![CDATA[Luis Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Costa Rica  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<volume>44</volume>
<numero>2</numero>
<fpage>398</fpage>
<lpage>421</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-34662018000200398&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-34662018000200398&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-34662018000200398&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  Una Política Nacional de Medicamentos es un recurso formal que permite ordenar, priorizar, planificar, controlar y evaluar; los aspectos más relevantes del ciclo de los medicamentos en un país.  Objetivo:  Revisar documentación concerniente al tema de Política Nacional de Medicamentos en América Latina.  Fuente de datos:  Documentos disponibles en la web referidos con el tópico.  Síntesis de los datos:  Una política surge a partir de un proceso consultivo complejo con la pretensión de lograr beneficios para la población a partir de la toma de decisiones basadas en la evidencia científica, lo que impone que los diversos aspectos relacionados con la gestión de la política deben estar actualizados, para responder a las necesidades y los cambios que experimenta una sociedad. En América Latina algunos países disponen de una política nacional de medicamentos; sin embargo, otros solo disponen de listas de medicamentos esenciales.  Conclusiones:  Existen en América Latina, experiencias positivas en la construcción de las Políticas Nacionales de Medicamentos y oportunidades de mejora en varios países. A pesar de los avances logrados en la construcción e implementación de esas políticas, todavía hay personas sin acceso a medicamentos en algunas regiones y se requiere incluir aspectos relacionados con la medicina tradicional, herbolarios, fitofármacos y biotecnológicos; también se deben mejora la promoción científica y los estudios poscomercialización de los medicamentos. En el caso particular de Costa Rica, se tiene una larga tradición de utilización de una política de medicamentos esenciales en la Seguridad Social, pero se carece de la consecuente política nacional.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  A National Drugs Policy is a formal resource that allows ordering, prioritizing, planning, controlling and evaluating the most relevant aspects of the medicines cycle in a country.  Objective:  To review documentation concerning the topic of National Drugs Policy in Latin America.  Data sources:  Documents available on the web referring to the topic.  Data synthesis: A policy arises from a complex consultative process with the aim of achieving benefits for the population from the decision making based on scientific evidence, which requires that the various aspects related to the management of the policy should be updated to respond to the needs and changes that a society experiences. In Latin America, some countries have a national drugs policy; however, others only have lists of essential medicines.  Conclusions:  There are positive experiences in Latin America in the construction of National Drugs Policies and opportunities for improvement in several countries. Despite the progress made in the construction and implementation of these policies, there are still people without access to medicines in some regions and it is necessary to include aspects related to traditional medicine, herbalists, phytopharmaceuticals and biotechnology. Scientific promotion and post-marketing studies of medicines should also be improved. In the particular case of Costa Rica, there is a long tradition of using an essential medicines policy in Social Security, but they lack of the consequent national policy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Política]]></kwd>
<kwd lng="es"><![CDATA[medicamento]]></kwd>
<kwd lng="es"><![CDATA[medicamentos esenciales]]></kwd>
<kwd lng="es"><![CDATA[salud]]></kwd>
<kwd lng="en"><![CDATA[Policy]]></kwd>
<kwd lng="en"><![CDATA[drug]]></kwd>
<kwd lng="en"><![CDATA[essential medicines]]></kwd>
<kwd lng="en"><![CDATA[health]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quick]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Essential Drugs and Medicines Policy Department. WHO Policy Perspectives of Medicines-How to develop and implement a national drug policy]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Abegunde]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Edejer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[The world medicines situation 2011. Medicine expenditures]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machinea]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Titelman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Uthoff]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[La protección social de cara al futuro: Acceso, financiamiento y solidaridad]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Chile ]]></publisher-loc>
<publisher-name><![CDATA[CEPAL]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sáinz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Equity in Latin America since the 1990s]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Chile ]]></publisher-loc>
<publisher-name><![CDATA[Economic and Social Affairs]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno-Brid]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Nápoles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La educación superior y el desarrollo económico en América Latina]]></article-title>
<source><![CDATA[Rev Iberoam Educ Super]]></source>
<year>2010</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>171-88</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>WHO Expert Committee</collab>
<source><![CDATA[The selection and use of essential medicines. Iincluding the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children. WHO Technical Report Series, No. 994]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garzón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Latin America and Drug Policy. Council of International Relations of Latin America and Caribbean RIAL reports]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Post-UNGASS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watkins]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Informe Desarrollo Humano. Más allá de la escasez: Poder, pobreza y la crisis mundial del agua]]></source>
<year>2006</year>
<publisher-loc><![CDATA[EE. UU. ]]></publisher-loc>
<publisher-name><![CDATA[PNUD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preventing medication errors A summary]]></article-title>
<source><![CDATA[Am J Health-System Pharmacy]]></source>
<year>2007</year>
<volume>64</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>S3-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ch]]></surname>
<given-names><![CDATA[Blouin]]></given-names>
</name>
<name>
<surname><![CDATA[Drager]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[International Trade in Health Services and The GATS. Current Issues and Debates]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Washington, D. C. ]]></publisher-loc>
<publisher-name><![CDATA[The Work Bank]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Política Nacional de Medicamentos]]></article-title>
<source><![CDATA[Rev Saúde Pública]]></source>
<year>2000</year>
<volume>34</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>206-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tolentino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Política nacional de medicamentos en Brasil Una visión general]]></article-title>
<source><![CDATA[Rev Peruana Med Experimen Salud Pública]]></source>
<year>2009</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>544-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Nacional de Medicamentos en la Reforma de Salud]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Chile ]]></publisher-loc>
<publisher-name><![CDATA[MINSA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementación de la Política Nacional de Medicamentos de la Reforma de la Salud percepción del profesional farmacéutico]]></article-title>
<source><![CDATA[Rev Chilena Salud Pública]]></source>
<year>2011</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reforma del sector salud y la política farmacéutica en Perú]]></article-title>
<source><![CDATA[Cad Saúde Pública]]></source>
<year>2002</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1121-38</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Política farmacéutica nacional Impacto en el Uso Racional de Medicamentos en el Perú]]></article-title>
<source><![CDATA[UCV-SCIENTIA]]></source>
<year>2015</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>82-90</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alcalde]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Nigenda]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sistema de salud de Perú]]></article-title>
<source><![CDATA[Salud pública Méx]]></source>
<year>2011</year>
<volume>53</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>243-54</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leyva]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dreser]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reich]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hacia una política farmacéutica integral para México]]></article-title>
<source><![CDATA[Salud pública Méx]]></source>
<year>2006</year>
<volume>48</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>179-80</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pagán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Polsky]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Self-Medication and Health insurance coverage in Mexico]]></article-title>
<source><![CDATA[Health Pol]]></source>
<year>2006</year>
<volume>75</volume>
<page-range>170-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dreser]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Heredia]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retos y oportunidades para el desarrollo de la política farmacéutica nacional en México]]></article-title>
<source><![CDATA[Salud pública Méx]]></source>
<year>2013</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>329-36</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud de Bolivia. Dirección General de Servicios de Salud. Unidad de Medicamentos y Tecnología en Salud</collab>
<source><![CDATA[Lista Nacional de Medicamentos Esenciales - LINAME 2014-2016, Regulación Farmaceútica No. 20/Ministerio de Salud. Serie: Documentos Técnico- Normativos No. 367]]></source>
<year>2014</year>
<publisher-loc><![CDATA[La Paz ]]></publisher-loc>
<publisher-name><![CDATA[Área de Impresión]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Nacional de Medicamentos]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Panamá ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vélez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Buriticá]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Arango]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La política farmacéutica nacional en Colombia y la reforma de la seguridad social acceso y uso racional de medicamentos. Cad]]></article-title>
<source><![CDATA[Saúde Pública]]></source>
<year>2002</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1025-39</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<collab>Consejo Nacional de Política Económica y Social</collab>
<source><![CDATA[Política Farmacéutica Nacional]]></source>
<year>2012</year>
<publisher-loc><![CDATA[República de Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Departamento Nacional de Planeación]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>Comisión Legislativa Nacional</collab>
<source><![CDATA[Ley de Medicamentos]]></source>
<year>2000</year>
<publisher-loc><![CDATA[República Bolivariana de Venezuela ]]></publisher-loc>
<publisher-name><![CDATA[Gaceta oficial nº 37.006]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mena]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Cuadro Básico de Medicamentos Esenciales. Santo Domingo,]]></source>
<year>2015</year>
<publisher-loc><![CDATA[República Dominicana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Farmacéutica Nacional]]></source>
<year>2007</year>
<publisher-loc><![CDATA[República Dominica ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Política de Medicamentos para el MERCOSUR, Bolivia y Chile. (Anexo IV MERCOSUR/IIICMC Ext./DT N.º 2/02). III Reunión Extraordinaria del Consejo del Mercado Común de, 18 febrero de 2002]]></source>
<year>2002</year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kusonoki]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Andina de Medicamentos]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Perú ]]></publisher-loc>
<publisher-name><![CDATA[Comisión técnica subregional para la política de acceso a medicamentos, ORAS-CONHU]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tarragona]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[de la Puente]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Nacional de Medicamentos. ¿Qué se hizó? ¿Qué queda por hacer?]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Argentina ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud. Presidencia de la Nación. Unidad de Análisis Económico en Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Política nacional de los medicamentos]]></source>
<year>2011</year>
<publisher-loc><![CDATA[El Salvador ]]></publisher-loc>
<publisher-name><![CDATA[Organización Panamericana de la Salud/Ministerio de Salud (MINSAL)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Cuadro Nacional de Medicamentos Básicos. Consejo Nacional de Salud. Comisión de Medicamentos e Insumos. República del Ecuador. 8va revisión]]></source>
<year>2010</year>
<publisher-loc><![CDATA[República del Ecuador ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz-Prado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galarza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cornejo León]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ponce]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acceso a medicamentos y situación del mercado farmacéutico en Ecuador]]></article-title>
<source><![CDATA[Rev Panam Salud Pública]]></source>
<year>2014</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>57-62</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos subutilizados en el ámbito comunitario, Área Salud Coronado, CR]]></article-title>
<source><![CDATA[Rev Costarricense Salud Pública]]></source>
<year>2006</year>
<volume>15</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>50-61</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública. Dirección de Registros y Controles del Ministerio de Salud</collab>
<source><![CDATA[Documento Marco teórico: Propuesta Política Nacional de Medicamentos]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Costa Rica ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública. República de Costa Rica</collab>
<source><![CDATA[Ley 9234: Ley reguladora de investigación biomédica. 25 abril 2014. San José,]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Costa Rica ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública. República de Costa Rica</collab>
<source><![CDATA[Reglamento 35244-S: Reglamento del Sistema Nacional de Farmacovigilancia. San José]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Costa Rica ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud</collab>
<source><![CDATA[Dirección de Registros y Controles. Validación de los Lineamientos de la Política Nacional de Medicamentos]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Costa Rica ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Política Nacional de Medicamentos]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Paraguay ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública y Bienestar Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frenk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Governance challenges in global health]]></article-title>
<source><![CDATA[NEJM]]></source>
<year>2013</year>
<volume>368</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>936-42</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bauer]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Briss]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bowman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of chronic disease in the 21st century elimination of the leading preventable causes of premature death and disability in the USA]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>384</volume>
<numero>9937</numero>
<issue>9937</issue>
<page-range>45-52</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoebert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National medicines policies a review of the evolution and development processes]]></article-title>
<source><![CDATA[J Pharmaceut Pol Pract]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>5</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holloway]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[WHO essential medicines policies and use in developing and transitional countries an analysis of reported policy implementation and medicines use surveys]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year>2014</year>
<volume>11</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Traulsen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almarsdóttir]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The argument for pharmaceutical policy]]></article-title>
<source><![CDATA[Pharm World Sci]]></source>
<year>2005</year>
<volume>27</volume>
<page-range>7-12</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Traulsen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almarsdóttir]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical policy and the lay public]]></article-title>
<source><![CDATA[Pharm World Sci,]]></source>
<year>2005</year>
<volume>27</volume>
<page-range>273-7</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lancaster]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ritter]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Examining the construction and representation of drugs as a policy problem in Australia&amp;apos;s National Drug Strategy documents 1985-2010]]></article-title>
<source><![CDATA[Internat J Drug Pol]]></source>
<year>2014</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>81-7</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rovira]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The World Bank, pharmaceutical policies, and health reforms in Latin America]]></article-title>
<source><![CDATA[Internat J Health Ser]]></source>
<year>2005</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>691-717</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mordujovich]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Implementación de una estrategia nacional de uso racional de medicamentos (Propuesta regional)]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Brasil ]]></publisher-loc>
<publisher-name><![CDATA[OMS/OPS]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
